2. Infection

Infection

Infection

Related Products

PDF 70.44 MB

Infection is a pathophysiological process that involves the invasion and colonization of a living organism (host) by disease-causing infectious agents, the reaction of host tissues to these agents and the toxins they produce, and the transmission of infectious agents to other hosts. Common infectious agents include viruses, viroids, prions, bacteria, nematodes, arthropods, and other macroparasites such as tapeworms. Hosts can fight infections using their immune system. Mammals often engage both innate and adaptive immune systems to eliminate infectious agents or inhibit their growth and transmission. When infection occurs, anti-infective drugs can suppress the infection. Several broad types of anti-infective drugs exist, depending on the type of organism targeted; they include antibacterial (antibiotic), antiviral, antifungal and antiparasitic agents.

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-106575
    Nifurzide 39978-42-2 98%
    Nifurzide, a nitrofuran derivative, is used as an intestinal antiinfectious agent. Nifurzide shows strong bactericidal effect.
    Nifurzide
  • HY-106590
    Saccharocin 86630-31-1 98%
    Saccharocin (Antibiotic KA 5685) is effective against Gram-positive and negative bacteria, and also against aminoglycoside antibiotic-resistant bacteria.
    Saccharocin
  • HY-106774
    R-61837 100241-46-1 98%
    R-61837 is a synthetic antirhinoviral compound with significant in vitro activity. R-61837 is 10 times and 57 times more active against human rhinovirus type 9 (HRV-9) than Enviroxime and dichloroflavone (DCF), respectively, and is more active against human rhinovirus type 2 (HRV-2 ) were 5 times and 10 times higher respectively.
    R-61837
  • HY-106775
    FR-900482 108814-63-7 98%
    FR-900482 is highly sensitive to Bacillus stearothermophilus var. calidolactis C 953 and has anti-P388, B16, EL4, FM3A, L1210, BHK-21 and other cell activities.
    FR-900482
  • HY-107001
    DPC 961 214287-88-4 98%
    DPC 961 (DMP 961) is a non-nucleoside reverse transcriptase inhibitor (NNRTI). DPC 961 is a potent and specific inhibitor of HIV-1 reverse transcriptase, which inhibits the activity of HIV-1 reverse transcriptase in a non-competitive manner, thereby preventing viral replication. DPC 961 can be used for research on AIDS.
    DPC 961
  • HY-107003
    Opaviraline 178040-94-3 98%
    Opaviraline (GW420867X) is an anti-HIV-1 reverse transcriptase inhibitor.
    Opaviraline
  • HY-107027
    Polymyxin E2 sulfate 1338055-88-1 98%
    Polymyxin E2 sulfate is an antibiotic produced by the soil bacterium Bacillus polymyxa.
    Polymyxin E2 sulfate
  • HY-107211
    Echinocandin B nucleus 79411-15-7 98%
    Echinocandin B nucleus (A-30912 A nucleus) is the reaction product catalyzed by Echinocandin B (HY-125723) deacylase. Echinocandin B nucleus serves as an intermediate for the synthesis of semi-synthetic antifungal agents.
    Echinocandin B nucleus
  • HY-107338
    Denotivir 51287-57-1 98%
    Denotivir (Vratizolin) is an orally active antiviral agent for herpes simplex virus (HSV) and varicella-zoster virus (VZV). Denotivir inhibits the proliferation of various cancer cells, and exhibits anti-leukemic activity. Denotivir inhibits the generation of TNF-α, IL-1 and IL-6, exhibits immunosuppressive efficacy.
    Denotivir
  • HY-107468
    PL-100 612547-11-2 98%
    PL-100 is a potent HIV-1 protease inhibitor with a Ki of 36 pM and an EC50 of 16 nM. PL-100 inhibits viral replication by suppressing HIV-1 protease activity and demonstrates excellent antiviral efficacy against drug-resistant HIV strains. PL-100 can be used in research on drug-resistant HIV disease.
    PL-100
  • HY-107492
    Ethaboxam 162650-77-3 98%
    Ethaboxam is a β-tubulin inhibitor that can be used as anti-oomycete fungicide.
    Ethaboxam
  • HY-108191
    Paldimycin A 101411-70-5 98%
    Paldimycin A (Antibiotic 273a1α) is an antibiotic derived from Streptomyces paulus, primarily targeting Gram-positive bacteria. Paldimycin A exerts its antibacterial effects by interfering with bacterial protein synthesis and cell membrane function.
    Paldimycin A
  • HY-108255
    HIV-1 inhibitor-60 1443461-21-9 98%
    HIV-1 inhibitor-60 (compound 45) is an HIV inhibitor with the potential for the research of infection diseases.
    HIV-1 inhibitor-60
  • HY-108422
    Benodanil 15310-01-7 98%
    Benodanil (NSC 100499) is a group of benzanilide fungicide, is used extensively in agriculture.
    Benodanil
  • HY-10852A
    Arterolane maleate 959520-73-1 98%
    Arterolane (OZ 277) (maleate) is an orally active antimalarial. Arterolane exhibits potent activity against erythrocytic stages of P. falciparum and Plasmodium vivax. Arterolane (maleate) is promising for research of falciparum malaria.
    Arterolane maleate
  • HY-10852R
    Arterolane (Standard) 664338-39-0
    Arterolane (Standard) is the analytical standard of Arterolane. This product is intended for research and analytical applications. Arterolane is an antimalarial agent, with IC50 of both 1.1 nM against P. falciparum Ro73 and W2, respectively.
    Arterolane (Standard)
  • HY-108954
    A-30912A nucleus hydrochloride 1029890-89-8 98%
    A-30912A nucleus hydrochloride is the product of Echinocandin B (ECB) deacylase-catalyzed antifungal agent A-30912A (HY-125723).
    A-30912A nucleus hydrochloride
  • HY-108989
    FMDP 96920-07-9 98%
    FMDP is an inhibitor of GlcN-6-P Synthase with an anti-candidal activity. FMDP can be covalently attached to a polyethylene glycol as a nanoparticle shows strong anticancer activity.
    FMDP
  • HY-109072
    Riamilovir 123606-06-4 98%
    Riamilovir is an antiviral drug whose activity is primarily directed against RNA viruses. Riamilovir acts directly on the virus's RNA-dependent RNA polymerase, thereby preventing the virus from replicating. This mechanism allows Riamilovir to effectively reduce the amount of virus, accelerate the relief of symptoms, and help reduce the severity of the disease. Riamilovir can be used in the study of acute respiratory viral infections caused by new variants of SARS-CoV-2.
    Riamilovir
  • HY-10964R
    Vadimezan (Standard) 117570-53-3 98%
    Vadimezan (Standard) (DMXAA (Standard)) is the analytical standard of Vadimezan (HY-10964). This product is intended for research and analytical applications. Vadimezan (DMXAA; ASA-404), the tumor vascular disrupting agent (tumor-VDA), is a murine agonist of the stimulator of interferon genes (STING) and also a potent inducer of type I IFNs and other cytokines. Vadimezan is unable to activate human STING. Vadimezan has anti-influenza virus H1N1-PR8 activities.
    Vadimezan (Standard)
Cat. No. Product Name / Synonyms Application Reactivity